Agenda - Council Work Session - 04/11/2023

Home

HF100 NINTH ENGROSSMENT REVISOR BD 110100-9 22.1 (4) reviewing developments in the study of cannabis flower, cannabis products, artificially 22.2 derived cannabinoids, lower -potency edible products, and hemp -derived consumer products; 22.3 (5) taking public testimony; and 22.4 (6) making recommendations to the Office of Cannabis Management. 22.5 (b) At its discretion, the advisory council may examine other related issues consistent 22.6 with this section. 22.7 Sec. 4. [342.041 STUDIES; REPORTS. 22.8 (a) The office shall conduct a study to determine the expected size and growth of the 22.9 regulated cannabis industry, including an estimate of the demand for cannabis flower and 22.10 cannabis products, the number and geographic distribution of cannabis businesses needed 22.11 to meet that demand, and the anticipated business from residents of other states. 22.12 (b) The office shall conduct a study to determine the size of the illicit cannabis market, 22.13 the sources of illicit cannabis flower and illicit cannabis products in the state, the locations 22.14 of citations issued and arrests made for cannabis offenses, and the subareas, such as census 22.15 tracts or neighborhoods, that experience a disproportionately large amount of cannabis 22.16 enforcement. 22.17 (c) The office shall conduct a study on impaired driving to determine the number of 22.1 s accidents involving one or more drivers who admitted to using cannabis flower, cannabis 22.19 products, lower -potency he edibles, or hemp -derived consumer products, or who tested 22.20 positive for cannabis or tetrahydrocannabinol, the number of arrests of individuals for 22.21 impaired driving in which the individual tested positive for cannabis or tetrahydrocannabinol, 22.22 and the number of convictions for driving under the influence of cannabis flower, cannabis 22.23 products, lower -potency hemp edibles, hemp -derived consumer products, or 22.24 tetrahvdrocannabinol. 22.25 (d) The office shall provide preliminary reports on the studies conducted pursuant to 22.26 paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports 22.27 to the legislature by January 15, 2025. Each report may be consolidated with other annual 22.28 reports that the office is required to submit. 22.29 (e) The office shall conduct a studv on the state's mental health system and substance 22.30 use disorder treatment system to determine the rates at which individuals access those 22.31 systems. At a minimum, the report shall include information about the number of people 22.32 admitted to emergency rooms for treatment of a mental illness or substance use disorder, 22.33 ordered by a court to participate in mental health or substance use programming, and who Article 1 Sec. 4. 22